| ISIN | LU2488092649 |
|---|---|
| Valorennummer | 119403766 |
| Bloomberg Global ID | |
| Fondsname | Kieger Sustainable Healthcare Fund Class B EUR Accumulating |
| Fondsanbieter |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Telefon: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
| Fondsanbieter | Kieger AG |
| Vertreter in der Schweiz |
ACOLIN Fund Services AG Zürich Telefon: +41 44 396 96 96 |
| Distributor(en) | |
| Anlagekategorie | Aktienfonds |
| EFC-Kategorie | |
| Anteilskategorie | Accumulation |
| Domizilland | Luxemburg |
| Konditionen bei der Ausgabe | keine Ausgabekommission und/oder Gebühren zugunsten des Fonds (Ausgabe erfolgt zum Inventarwert) |
| Konditionen bei der Rücknahme | Keine Rücknahmekommission und/oder Gebühren zugunsten des Fonds (Rücknahme erfolgt zum Inventarwert) |
| Investment-Strategie *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related issuers worldwide (including Emerging Markets). The Sub-Fund aims to have a positive impact on society by investing in sustainable companies with current or future activities positively contributing to good health and well-being. The objective is reached by investing in innovative companies with differentiated products and/or services that are leaders in sustainability as identified through a proprietary sustainability framework developed by the Investment Manager. |
| Besonderheiten |
| Aktueller Preis * | 102.14 EUR | 30.10.2025 |
|---|---|---|
| Vorheriger Preis * | 101.92 EUR | 29.10.2025 |
| 52 Wochen Hoch * | 119.54 EUR | 05.02.2025 |
| 52 Wochen Tief * | 93.66 EUR | 07.08.2025 |
| NAV * | 102.14 EUR | 30.10.2025 |
| Ausgabepreis * | ||
| Rücknahmepreis * | ||
| Schlusskurs * | ||
| Indikativer Minimalpreis | ||
| Fondsvermögen *** | 189'962'122 | |
| Anteilsklassevermögen *** | 134'241 | |
| Trading Information SIX | ||
| YTD-Performance | -7.84% |
31.12.2024 - 30.10.2025
31.12.2024 30.10.2025 |
|---|---|---|
| YTD-Performance (in CHF) | -9.08% |
31.12.2024 - 30.10.2025
31.12.2024 30.10.2025 |
| 1 Monat | +4.39% |
30.09.2025 - 30.10.2025
30.09.2025 30.10.2025 |
| 3 Monate | +2.73% |
30.07.2025 - 30.10.2025
30.07.2025 30.10.2025 |
| 6 Monate | -1.74% |
30.04.2025 - 30.10.2025
30.04.2025 30.10.2025 |
| 1 Jahr | -9.60% |
30.10.2024 - 30.10.2025
30.10.2024 30.10.2025 |
| 2 Jahre | +7.79% |
30.10.2023 - 30.10.2025
30.10.2023 30.10.2025 |
| 3 Jahre | +2.14% |
06.07.2023 - 30.10.2025
06.07.2023 30.10.2025 |
| 5 Jahre | - | - |
| Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Eli Lilly and Co | 6.32% | |
|---|---|---|
| AstraZeneca PLC | 5.81% | |
| Abbott Laboratories | 5.56% | |
| Roche Holding AG | 5.37% | |
| Novartis AG Registered Shares | 5.22% | |
| Boston Scientific Corp | 4.44% | |
| Vertex Pharmaceuticals Inc | 3.92% | |
| UnitedHealth Group Inc | 3.70% | |
| Danaher Corp | 3.52% | |
| Stryker Corp | 3.46% | |
| Letzte Daten-Aktualisierung | 31.07.2025 | |
| TER *** | 0.99% |
|---|---|
| Datum TER *** | 30.09.2023 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 0.85% |
| Ongoing Charges *** | 0.99% |
|
SRRI ***
|
|
| Datum SRRI *** | 30.09.2025 |